Sripad Umesh
Transaction: 06/01/2026
OTHER
Change
0
Price
Not reported
Filing
06/03/2026
Type
OTHER
LifeMD, Inc.
LFMDP • Medical - Pharmaceuticals
$3.08
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$147.19M
Growth
30.9%
Cash Flow
2/5
Trend
Volatile
Evidence
Positive revenue growth · 5.7%Manageable debt level · 0.27Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:39 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.08
Change0.00%
Shares Out47.79M
Market Cap$147.19M
Enterprise Value$122.05M
52W Range18.50 - 24.25
Beta2.06
P/E-6.92
P/S0.72
P/B18.48
P/FCF-10.78
EV/Sales0.60
Price$3.08
Change0.00%
Shares Out47.79M
Market Cap$147.19M
Enterprise Value$122.05M
52W Range18.50 - 24.25
Beta2.06
P/E-6.92
P/S0.72
P/B18.48
P/FCF-10.78
EV/Sales0.60
EV/EBITDA-9.23
EV/FCF-8.94
Earnings Yield-14.44%
FCF Yield-9.27%
Dividend Yield1.62%
Gross Margin79.75%
Oper. Margin-3.95%
Profit Margin-3.66%
Debt/Eq0.27
Current Ratio1.25
Quick Ratio1.18
Revenue 5Y30.92%
Target$7.67
Target Upside149.03%
Target Median$8.00
Target Range5.00 - 10.00
Volume2.00
Avg Volume2.10K
EPS Surprise-0.06
Investment DNA
How strong this company looks for long-term investors
50
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
64/100
Growth Potential
Revenue and expansion
84/100
Price Attractiveness
Cheap or expensive today
71/100
Why this score▼
Positive revenue growth · 5.7%Manageable debt level · 0.27Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 10 analyst votes · 2026-09-05
100/100
Bullish
Bullish
10
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$5.00
Mean
$8.20
Median
$9.00
High
$10.00
Insider Transactions
Recent executive and insider activity
Sripad Umesh
Transaction: 06/01/2026
BUY
Change
+75,000
Price
Not reported
Filing
06/03/2026
Type
BUY
Kavthekar Atul
Transaction: 05/11/2026
BUY
Change
+337,500
Price
Not reported
Filing
05/13/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Sripad Umesh | OTHER | 0 | Not reported | 06/01/2026 | 06/03/2026 |
| Sripad Umesh | BUY | +75,000 | Not reported | 06/01/2026 | 06/03/2026 |
| Kavthekar Atul | BUY | +337,500 | Not reported | 05/11/2026 | 05/13/2026 |
| Pisano Christopher A | BUY | +200,000 | Not reported | 03/30/2026 | 04/01/2026 |
| Kavthekar Atul | OTHER | 0 | Not reported | 03/16/2026 | 04/01/2026 |
| Pisano Christopher A | OTHER | 0 | Not reported | 03/16/2026 | 04/01/2026 |
| FRIEDEMAN JESSICA | SELL | -15,000 | $3.61 | 12/09/2025 | 12/11/2025 |
| LAROVERE JOAN | BUY | +22,365 | Not reported | 10/06/2025 | 10/08/2025 |
| Strawn John R Jr | BUY | +22,365 | Not reported | 10/06/2025 | 10/08/2025 |
| Simon Roberto | BUY | +22,365 | Not reported | 10/02/2025 | 10/06/2025 |
| MACRAE CALUM ARCHIBALD | BUY | +22,365 | Not reported | 10/02/2025 | 10/06/2025 |
| DiTrolio Joseph | BUY | +22,365 | Not reported | 10/02/2025 | 10/06/2025 |
| Alvarez Nicholas P | SELL | -75,000 | $5.92 | 09/10/2025 | 09/12/2025 |
| Dray Shayna Webb | BUY | +30,000 | Not reported | 08/22/2025 | 08/26/2025 |
| Alvarez Nicholas P | BUY | +100,000 | Not reported | 08/22/2025 | 08/26/2025 |
| Benathen Marc David | BUY | +87,000 | Not reported | 08/22/2025 | 08/26/2025 |
| FRIEDEMAN JESSICA | BUY | +50,000 | Not reported | 08/22/2025 | 08/26/2025 |
| Galluppi Stefan | BUY | +30,000 | Not reported | 08/22/2025 | 08/26/2025 |
| STAN MARIA E. | BUY | +20,000 | Not reported | 08/22/2025 | 08/26/2025 |
| Wijnker Dennis | BUY | +25,000 | Not reported | 08/22/2025 | 08/26/2025 |